December 27, 2024 08:36 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Manmohan Singh will be remembered as a kind person, a learned economist, and a leader dedicated to reforms: PM Modi | Russian ambassador to India Denis Alipov grieves Manmohan Singh's demise | Mumbai terror attack shook Manmohan Singh badly, recalls former deputy NSA | I have lost a mentor and guide: Rahul Gandhi writes on Manmohan Singh's demise | Manmohan Singh left strong imprint on our economic policy over years: PM Modi | A rare leader who spoke softly but achieved monumental strides: Gautam Adani mourns Manmohan Singh's death | Instagram influencer and freelance RJ Simran Singh dies by suicide in Gurugram | Anna University sexual assault case: Accused is a DMK worker, claims BJP's Annamalai | Celebrities too responsible for crowd control: Telangana CM Revanth Reddy to Telugu filmdom amid Pushpa 2 stampede row | Boat capsizes off Calangute Beach in Goa; 1 killed, 20 rescued
NHRC issues notice to Delhi CS, DCGI after epilepsy drug fails quality test

NHRC issues notice to Delhi CS, DCGI after epilepsy drug fails quality test

Dec 30, 2023, at 05:24 am

New Delhi/UNI: The National Human Rights Commission (NHRC) issued notices to Delhi Chief Secretary, Drugs Controller General of India (DCGI), and Police Commissioner on Friday after the epilepsy drug ‘Sodium Valproate’ reportedly failed quality testing.

Optimus submits interim result of phase III clinical trials for Molnupiravir capsules

Optimus submits interim result of phase III clinical trials for Molnupiravir capsules

Jul 21, 2021, at 10:54 pm

Hyderabad/UNI: Optimus Pharma on Wednesday said that it has submitted the interim result of phase III clinical trials for orally administered Molnupiravir capsules on patients with mild covid infection.

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Feb 20, 2021, at 01:53 am

Chennai/IBNS: The Madras High Court has issued a notice to the Centre over a petition to declare India's indigenous coronavirus vaccine -'Covishield'- developed by Pune-based Serum Institute as "unsafe".